Lucence
Dr. Kao Chin Ngeow is Lucence’s Chief Technology Officer. Kao Chin completed his DPhil at the Ludwig Institute for Cancer Research, University of Oxford in 2016, and his Sc.B. in Biomedical Engineering at Brown University in 2010. His research has been published in Nature Communications and PNAS. Kao Chin leads a team of outstanding scientists in developing key ultrasensitive platform technologies for circulating tumor DNA and RNA profiling at Lucence.
This person is not in any offices
Lucence
Lucence is a precision oncology company committed to bringing clarity to cancer care. Lucence makes ultrasensitive non-invasive liquid biopsy tests to provide doctors and their patients life-changing information to enable earlier detection and effective treatment.